226 related articles for article (PubMed ID: 35128573)
1. Enhancing solubility and bioavailability of coenzyme Q
Lamichhane S; Seo JE; Keum T; Noh G; Bashyal S; Cho SW; Lee EH; Lee S
Arch Pharm Res; 2022 Jan; 45(1):29-37. PubMed ID: 35128573
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of docetaxel solubility using binary and ternary solid dispersion systems.
Lim SM; Pang ZW; Tan HY; Shaikh M; Adinarayana G; Garg S
Drug Dev Ind Pharm; 2015; 41(11):1847-55. PubMed ID: 25721984
[TBL] [Abstract][Full Text] [Related]
3. Improved water dispersion and bioavailability of coenzyme Q10 by bacterial cellulose nanofibers.
Li Y; Yang Q; Liu B; Zhang Q; Liu Y; Zhao X; Li S
Carbohydr Polym; 2022 Jan; 276():118788. PubMed ID: 34823798
[TBL] [Abstract][Full Text] [Related]
4. Application of scCO
Yang R; Li Y; Li J; Liu C; Du P; Zhang T
Drug Dev Ind Pharm; 2018 Feb; 44(2):289-295. PubMed ID: 29082762
[TBL] [Abstract][Full Text] [Related]
5. Soluplus-Mediated Diosgenin Amorphous Solid Dispersion with High Solubility and High Stability: Development, Characterization and Oral Bioavailability.
Liu P; Zhou JY; Chang JH; Liu XG; Xue HF; Wang RX; Li ZS; Li CS; Wang J; Liu CZ
Drug Des Devel Ther; 2020; 14():2959-2975. PubMed ID: 32801637
[TBL] [Abstract][Full Text] [Related]
6. Solubility and bioavailability enhancement study of lopinavir solid dispersion matrixed with a polymeric surfactant - Soluplus.
Zi P; Zhang C; Ju C; Su Z; Bao Y; Gao J; Sun J; Lu J; Zhang C
Eur J Pharm Sci; 2019 Jun; 134():233-245. PubMed ID: 31028820
[TBL] [Abstract][Full Text] [Related]
7. Studies on the curcumin phospholipid complex solidified with Soluplus
Wang J; Wang L; Zhang L; He D; Ju J; Li W
J Pharm Pharmacol; 2018 Feb; 70(2):242-249. PubMed ID: 29148063
[TBL] [Abstract][Full Text] [Related]
8. Molecular interaction between glimepiride and Soluplus®-PEG 4000 hybrid based solid dispersions: Characterisation and anti-diabetic studies.
Reginald-Opara JN; Attama A; Ofokansi K; Umeyor C; Kenechukwu F
Int J Pharm; 2015 Dec; 496(2):741-50. PubMed ID: 26581773
[TBL] [Abstract][Full Text] [Related]
9. Stability-enhanced hot-melt extruded amorphous solid dispersions via combinations of Soluplus® and HPMCAS-HF.
Alshahrani SM; Lu W; Park JB; Morott JT; Alsulays BB; Majumdar S; Langley N; Kolter K; Gryczke A; Repka MA
AAPS PharmSciTech; 2015 Aug; 16(4):824-34. PubMed ID: 25567525
[TBL] [Abstract][Full Text] [Related]
10. Preparation, characterization and in vitro/vivo evaluation of tectorigenin solid dispersion with improved dissolution and bioavailability.
Shuai S; Yue S; Huang Q; Wang W; Yang J; Lan K; Ye L
Eur J Drug Metab Pharmacokinet; 2016 Aug; 41(4):413-22. PubMed ID: 25669445
[TBL] [Abstract][Full Text] [Related]
11. Characterization and pharmacokinetics of coenzyme Q10 nanoparticles prepared by a rapid expansion of supercritical solution process.
Meng X; Zu Y; Zhao X; Li Q; Jiang S; Sang M
Pharmazie; 2012 Feb; 67(2):161-7. PubMed ID: 22512087
[TBL] [Abstract][Full Text] [Related]
12. Amorphous Salts Solid Dispersions of Celecoxib: Enhanced Biopharmaceutical Performance and Physical Stability.
Mukesh S; Joshi P; Bansal AK; Kashyap MC; Mandal SK; Sathe V; Sangamwar AT
Mol Pharm; 2021 Jun; 18(6):2334-2348. PubMed ID: 34003656
[TBL] [Abstract][Full Text] [Related]
13. Thermoanalytical and Fourier transform infrared spectral curve-fitting techniques used to investigate the amorphous indomethacin formation and its physical stability in Indomethacin-Soluplus® solid dispersions.
Lin SY; Lin HL; Chi YT; Huang YT; Kao CY; Hsieh WH
Int J Pharm; 2015 Dec; 496(2):457-65. PubMed ID: 26481469
[TBL] [Abstract][Full Text] [Related]
14. Enhanced Stability and Oral Bioavailability of Folic Acid-Dextran-Coenzyme Q
Luo M; Yang X; Ruan X; Xing W; Chen M; Mu F
J Agric Food Chem; 2018 Sep; 66(37):9690-9696. PubMed ID: 30141926
[TBL] [Abstract][Full Text] [Related]
15. Third-generation solid dispersion combining Soluplus and poloxamer 407 enhances the oral bioavailability of resveratrol.
Vasconcelos T; Prezotti F; Araújo F; Lopes C; Loureiro A; Marques S; Sarmento B
Int J Pharm; 2021 Feb; 595():120245. PubMed ID: 33484925
[TBL] [Abstract][Full Text] [Related]
16. On the inherent properties of Soluplus and its application in ibuprofen solid dispersions generated by microwave-quench cooling technology.
Shi NQ; Lai HW; Zhang Y; Feng B; Xiao X; Zhang HM; Li ZQ; Qi XR
Pharm Dev Technol; 2018 Jul; 23(6):573-586. PubMed ID: 27824281
[TBL] [Abstract][Full Text] [Related]
17. Stability and Bioavailability Enhancement of Telmisartan Ternary Solid Dispersions: the Synergistic Effect of Polymers and Drug-Polymer(s) Interactions.
Shi X; Xu T; Huang W; Fan B; Sheng X
AAPS PharmSciTech; 2019 Mar; 20(4):143. PubMed ID: 30887265
[TBL] [Abstract][Full Text] [Related]
18. Formulation development, characterization, and evaluation of bedaquiline fumarate - Soluplus
Pardhi VP; Patel M; Jain K
Pharm Dev Technol; 2024 Jun; 29(5):492-503. PubMed ID: 38682603
[TBL] [Abstract][Full Text] [Related]
19. Increased dissolution and oral absorption of itraconazole/Soluplus extrudate compared with itraconazole nanosuspension.
Zhang K; Yu H; Luo Q; Yang S; Lin X; Zhang Y; Tian B; Tang X
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1285-92. PubMed ID: 23562534
[TBL] [Abstract][Full Text] [Related]
20. Enhanced Biopharmaceutical Performance of Rivaroxaban through Polymeric Amorphous Solid Dispersion.
Metre S; Mukesh S; Samal SK; Chand M; Sangamwar AT
Mol Pharm; 2018 Feb; 15(2):652-668. PubMed ID: 29287144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
